QuanjerPH, TammelingGJ, CotesJE, PedersenOF, PeslinR, YernaultJC. Lung volumes and forced ventilatory flows. Official statement of the European Respiratory Society. Respir J Suppl, 1993; 16:5–40.
2.
FalaschettiE, Laiho, PrimatestaP, PurdonS. Prediction equations for normal and low lung function from the Health Survey for England. Eur Respir J, 2004; 23(3):456–463.
3.
StanojevicS, WadeA, StocksJ, HankinsonJ, CoatesAL, PanH, et al. Reference ranges for spirometry across all ages: a new approach. Am J Respir Crit Care Med, 2008; 177(3):253–260.
4.
QuanjerPH. Download software for diagnosing airway obstruction, COPD, and for an exhaustive set of predicted values for FEV1, FVC, and FEV1/FVC and their lower limits of normal. Version 3.1.0.118. http://www.spirxpert.com/gold.html. Accessed August 6, 2010.
StanojevicS, WadeA, StocksJ. Reference values for lung function: past, present and future. Eur Respir J, 2010; 36(1)12–19.
7.
HardieJA, BuistAS, VollmerWM, EllingsenI, BakkePS, MørkveO. Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers. Eur Respir J, 2002; 20(5):1117–1120.
8.
CelliBR, HalbertRJ, IsonakaS, SchauB. Population impact of different definitions of airway obstruction. Eur Respir J, 2003; 22(2):268–273.
9.
RobertsSD, FarberMO, KnoxKS, PhillipsGS, BhattNY, MastronardeJG, WoodKL. FEV1/FVC ratio of 70% misclassifies patients with obstruction at the extremes of age. Chest, 2006; 130(1):200–206.
10.
AggarwalAN, GuptaD, BeheraD, JindalSK. Comparison of fixed percentage method and lower confidence limits for defining limits of normality for interpretation of spirometry. Respir Care, 2006;(7)51:737–743.
11.
MillerMR, SteenbruggenI, QuanjerPH, RuppelG, CrapoRO, PedersenOF. Defining the lower limit of normal for FEV1/FVC (letter). Am J Respir Crit Care Med, 2007; 176(1):101–102.
12.
MillerMR. What defines abnormal lung function? (letter). Thorax, 2007; 62(2):1107.
13.
PetsonkEL, HnizdoE, AttfieldM. Definition of COPD GOLD stage I (letter). Thorax, 2007; 62(3):1107–1108.
14.
MedbøA, MelbyeH. Lung function testing in the elderly: can we still use the FEV1/FVC < 70% as a criterion for COPD?. Respir Med, 2007; 101(6):1097–1105.
15.
ShirtcliffeP, WeatherallM, MarshS, TraversJ, HansellA, McNaughtonA, et al. COPD prevalence in a random population survey: a matter of definition. Eur Respir J, 2007; 30(2):232–239.
16.
VollmerWM, GíslasonB, BurneyP, EnrightPL, GulsvikA, KocabasA, BuistAS. Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study. Eur Respir J, 2009; 34(3):588–597.
17.
MillerMR, PedersenOF, PellegrinoR, BrusascoV. Debating the definition of airflow obstruction: time to move on? (editorial). Eur Respir J, 2009; 34(3):527–528.
18.
SwanneyMP, RuppelG, EnrightPL, PedersenOF, CrapoRO, MillerMR, et al. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax, 2008; 63(12):1046–1051.
19.
OlofsonJ, BakeB, TengelinMN, HoultzB. COPD ‘diagnosis’ based on spirometric reference equations. Clin Respir J, 2008; 2(4):214–219.
20.
KoFW, WooJ, TamW, LaiCK, NgaiJ, KwokT, HuiDS. Prevalence and risk factors of airflow obstruction in an elderly Chinese population. Eur Respir J, 2008; 32(6):1472–1478.
21.
LauAC, IpMS, LaiCK, ChooKL, TangKS, YamLY, Chan-YeungM. Variability of the prevalence of undiagnosed airflow obstruction in smokers using different diagnostic criteria. Chest, 2008; 133(1):42–48.
22.
SchermerTR, SmeeleIJ, ThoonenBP, LucasAE, GrootensJG, van BoxemTJ, et al. Current clinical guideline definitions for airflow obstruction leads to substantial overdiagnosis of COPD in primary care. Eur Respir J, 2008; 32(4):945–952.
23.
LevyML, QuanjerPH, BookerR, CooperBG, HolmesS, SmallI. Diagnostic spirometry in primary care: proposed standards for general practice compliant with American Thoracic Society and European Respiratory Society recommendations. Prim Care Respir J, 2009; 18(3):130–147.
24.
SchermerTR, QuanjerPH. COPD screening in primary care: who is sick?. Prim Care Respir J, 2007; 16(1):49–53.
25.
Pérez-PadillaR, HallalPC, Vázquez-GarcíaJC, MuiñoA, MáquezM, LópezMV, et al. Impact of bronchodilator use on the prevalence of COPD in population-based samples. Int J COPD, 2007; 4(2):113–120.
26.
Vaz FragosoCA, ConcatoJ, McAvayG, Van NessPH, RochesterCL, YaggiHK, GillTM. The ratio of FEV1 to FVC as a basis for establishing chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 2010; 181(5):446–451.
27.
MillerMR, QuanjerPH, SwanneyMP, RuppelG, EnrightPL. Interpreting lung function data using 80 percent of predicted and 5 fixed thresholds misclassifies over 20% of patients. Chest, 2010 [epub ahead of print]. DOI: 10.1378/chest.10-0189.
28.
EnrightPL. GOLD stage I is not a COPD risk factor (letter). Thorax, 2007; 62(12):1107–1109.
29.
MillerMR, PincockAC. Predicted values: how should we use them?. Thorax, 1988; 43(4):265–267.
30.
American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis, 1991; 144(5):1202–1218.
31.
PellegrinoR, ViegiG, BrusascoV, CrapoRO, BurgosF, CasaburiR, et al. Interpretative strategies for lung function tests. Eur Respir J, 2005; 26(5):948–968.
32.
TownsendMC. Conflicting definitions of airways obstruction: drawing the line between normal and abnormal (editorial). Chest, 2007; 131(2):335–336.
33.
KerstjensHA. The GOLD classification has not advanced understanding of COPD (editorial). Am J Respir Crit Care Med, 2004; 170(3):212–214.
34.
EnrightP, QuanjerP. Don't diagnose mild COPD without confirming airway obstruction after an inhaled bronchodilator (editorial). Int J COPD, 2007; 4(2):89–90.
35.
CulverBH. Interpretation of spirometry: we can do better than the GOLD standard (editorial). Respir Care, 2006; 51(7):719–721.
36.
Agency for Healthcare Research and Quality; WiltT, NiewoehnerDE, KimCB. Use of spirometry for case finding, diagnosis, and management of chronic obstructive pulmonary disease (COPD). Evidence report/technology assessment 121. AHRQ Publication 05-E017-2; 2005.
37.
HnizdoE, GlindmeyerHW, PetsonkEL, EnrightP, BuistAS. Case definitions for chronic obstructive pulmonary disease. COPD, 2006; 3(2):95–100.
38.
HansenJE, SunXG, WassermanK. Spirometric criteria for airway obstruction. Use percentage of FEV1/FVC ratio below the fifth percentile, not < 70%. Chest, 2007; 131(2):349–355.
39.
CerveriI, CorsicoAG, AccordiniS, NinianoR, AnsaldoE, AntóJM, et al. Underestimation of airflow obstruction among young adults using FEV1/FVC <70% as a fixed cut-off: a longitudinal evaluation of clinical and functional outcomes. Thorax, 2008; 63(12):1040–1045.
40.
CerveriI, CorsicoAG, AccordiniS, AnsaldoE, GrossoA, NinianoR, et al. What defines airflow obstruction in asthma?. Eur Respir J, 2009; 34(3):568–573.